Abbott Laboratories

ABT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $30.58B $27.39B $20.85B $20.41B $20.25B $19.66B $19.05B $21.41B
Established Pharmaceutical Products $4.42B $4.29B $3.86B
Nutritional Products $7.23B $6.93B $6.90B
Diagnostic Products $7.50B $5.62B $4.81B
Vascular Products $2.90B
Medical Devices $11.37B $10.33B
Other $62.0M $237.0M $2.39B
Cost of Revenue $12.71B $12.41B $9.09B $8.75B $9.22B $9.19B $8.90B $10.02B
Gross Profit $17.87B $14.98B $11.76B $11.66B $11.03B $10.46B $10.15B $11.39B
Gross Margin 58.4% 54.7% 56.4% 57.1% 54.5% 53.2% 53.3% 53.2%
Operating Expenses
Research & Development $2.30B $2.26B
SG&A Expense $9.74B $9.18B $6.74B $6.79B $6.53B $6.37B $6.74B $7.37B
Operating Income $3.65B $1.56B $3.03B $2.87B $2.60B $2.13B $1.36B $1.63B
Operating Margin 11.9% 5.7% 14.5% 14.1% 12.8% 10.9% 7.1% 7.6%
Interest Expense $826.0M $904.0M $431.0M $163.0M $150.0M $145.0M $320.0M $359.0M
Pretax Income $2.87B $2.23B $1.41B $3.18B $2.52B $2.04B $-220.0M $1.24B
Income Tax Expense $539.0M $1.88B $350.0M $577.0M $797.0M $53.0M $-457.0M $110.0M
Net Income $2.37B $477.0M $1.40B $4.42B $2.28B $2.58B $5.96B $4.73B
Net Margin 7.7% 1.7% 6.7% 21.7% 11.3% 13.1% 31.3% 22.1%
EPS (Basic) $1.34 $0.27 $0.94 $2.94 $1.50 $1.64 $3.76 $3.03
EPS (Diluted) $1.33 $0.27 $0.94 $2.92 $1.49 $1.62 $3.72 $3.01
Shares Outstanding (Basic) 1.76B 1.74B 1.48B 1.50B 1.52B 1.56B 1.58B 1.56B
Shares Outstanding (Diluted) 1.77B 1.75B 1.48B 1.51B 1.53B 1.57B 1.59B 1.57B
Dividends Per Share $1.92
← Newer Page 2 of 3 Older →